Co-Stone Capital is a leading China based private equity firm headquartered in Shenzhen.
Business Model:
Revenue: $10.9M
Employees: 51-200
Address: 35F Main Building
City: Shenzhen
State: guangdong province
Zip: 518000
Country: CN
Co-Stone Capital is a leading China based private equity firm headquartered in Shenzhen. Founded more than 16 years ago, Co-Stone is one of China&s;s earliest private equity institutions. Co-Stone Capital focuses primarily on China domestic growth stage and Pre-IPO opportunities, basing investment decisions on a deep understanding of the Chinese economy and company specific growth patterns. We put heavy emphasis on stable growth in key industries, including TMT, healthcare, consumer products &a; services and advanced manufacturing. Co-Stone Capital approaches the capital markets with broad vision but detailed focus, maintaining an emphasis on value-adding services. We have invested in over 100 companies, the majority of which were lead investments and have successfully exited from 40 companies through IPO, M&a;A or reverse mergers. Our exit rates and ROI are far in excess of industry averages. Co-Stone Capital has assets under management in excess of 40 billion RMB, across funds covering private equity, venture capital, PIPE, M&a;A and fixed income. Co-Stone has a diverse capital base, with LPs ranging across large insurance groups, government guided funds, funds of funds, large corporations, entrepreneurs and high net worth individuals. Co-Stone Capital has received numerous accolades from Forbes, Zero2IPO,ChinaVenture and other industry publications which consistently rank us in the top 10. Co-Stone Capital is headquartered in Shenzhen, with offices in Beijing,Shanghai and Hefei.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
3/2018 | Give Me Five | Series B | - |
1/2016 | Janez T | Angel Round | 3M |
10/2018 | Changyang Tech | Series A | 2.9M |
4/2018 | Casiris | Series C | - |
5/2021 | Clustar | Series A | 3M |
5/2014 | Pharmplus | Series A | 1.6M |
4/2010 | TaiRui | Angel Round | 439.4k |
11/2022 | Dongfang Jingyuan Electron | Venture Round | 139.4M |
10/2018 | Gooosun | Series A | 2.9M |
4/2020 | 4Paradigm | Series C | 0 |
7/2019 | Yuepu | Corporate Round | 0 |
8/2017 | Wangteng Keji | Series A | 1.5M |
12/2017 | Lemobar | Series A | 7.6M |
9/2019 | Beijing Gene+ Technology | Series B | 0 |
6/2022 | Maxone Semi | Series B | - |
1/2022 | Moffett AI | Series A | - |
7/2021 | TransThera Biosciences | Series D | 100M |
1/2022 | Xingu Microelectronics | Series C | - |
11/2019 | benewtech | Series A | 2.8M |
4/2015 | lonwin | Series A | 1.6M |
3/2021 | Pico Interactive | Series B | 37.4M |
7/2017 | Carzone | Series B | 50M |
7/2016 | Xcar | Series A | 7.5M |
8/2017 | BlueStar | Post-IPO Equity | 17.7M |
5/2016 | Chuchujie | Series C | 153.9M |
4/2011 | Hair &a; Yard | Series B | 3.1M |
1/2020 | CF PharmTech | Series E | 90.5M |
12/2022 | InnerMedical | Series D | 43M |
4/2019 | aimingtai.com | Series A | 1.5M |
12/2022 | Core Medical Technology | Series C | - |
2/2023 | Hochuen Medical Technology | Series B | - |
5/2018 | Xinktech | Angel Round | - |
7/2018 | Xinktech | Series A | 3M |
6/2017 | Efort | Series D | 7.4M |
8/2022 | Baiying Bio | Series B | 72.6M |
1/2022 | Zhongke Wangwei Information Technology | Series C | - |
12/2021 | Vastai Technologies | Series B | 0 |
9/2016 | HOUGHTON STREET MEDIA | Post-IPO Equity | 16.3M |
1/2020 | Datacloak | Series A | 13M |
2/2015 | INTV | Angel Round | 482.2k |
11/2016 | iPlas | Series B | 51M |
12/2022 | Galaxis Automotion | Series E | - |
9/2021 | IASO Biotherapeutics | Series C | 0 |
12/2021 | Seesaw Coffee | Series B | - |
10/2021 | Creative Biosciences | Series D | 0 |
12/2017 | CloverSec Labs | Series A | 10.3M |
7/2017 | SenseTime | Series B | 0 |
7/2010 | Motie.com | Series B | 14.8M |
1/2019 | Carzone | Series C | 380M |
7/2015 | Muyingzhijia | Series C | 4.8M |
6/2019 | Clustar | Series A | 1.4M |
12/2021 | Seesaw Coffee | Series A | - |
2/2015 | Phoenix Travel Worldwide | Series B | - |
7/2015 | ULearning | Series B | 3.2M |
8/2020 | Biren Technology | Series B | 130M |
6/2022 | Huafu Information | Venture Round | - |
1/2022 | EigenCOMM | Series C | 157.3M |
11/2011 | Hair &a; Yard | Series C | 4.7M |
1/2015 | Carzone | Series A | 32.3M |
12/2022 | Readline | Series B | 0 |
12/2018 | Efort | Private Equity Round | 7.3M |
1/2023 | Anshi New Energy | Series B | 44.3M |
10/2020 | SmartMore Technology | Series A | 100M |
4/2015 | WINIT | Angel Round | 485.3k |
1/2018 | Pagoda | Series B | 0 |
6/2022 | Angstrong Tech | Series B | 0 |
7/2019 | Anlinkin | Seed Round | 2.9M |
12/2019 | Qdama | Series D | 0 |
4/2008 | Motie.com | Series A | 7.1M |
8/2016 | Che Jianding | Series A | 9M |
5/2022 | Boyin Bio | Angel Round | 1.4M |
1/2023 | Boyin Bio | Seed Round | 14.8M |
11/2022 | Jinsheng New Energy | Series B | - |
5/2019 | DeepDive Education | Series A | - |
8/2022 | Sunwoda Electric Vehicle Battery | Series A | 884.8M |
3/2010 | TONLY | Venture Round | 16.4M |
1/2016 | Zhangshang Tangyi | Series B | - |
11/2021 | Zhimeng Biopharma | Series B | 0 |
8/2019 | Lanrentingshu | Series D | - |
6/2022 | Huafu Information | Venture Round | - |
6/2022 | Angstrong Tech | Series B | 0 |
6/2022 | Maxone Semi | Series B | - |
1/2022 | EigenCOMM | Series C | 0 |
1/2022 | Moffett AI | Series A | - |
1/2022 | Xingu Microelectronics | Series C | - |
1/2022 | Zhongke Wangwei Information Technology | Series C | - |
12/2021 | Vastai Technologies | Series B | 0 |
12/2021 | Seesaw Coffee | Series B | - |
11/2021 | Zhimeng Biopharma | Series B | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|